These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Prostate Cancer: Prostate-specific Membrane Antigen Positron-emission Tomography/Computed Tomography or Positron-emission Tomography/Magnetic Resonance Imaging for Staging. Ferraro DA; Burger IA Top Magn Reson Imaging; 2020 Feb; 29(1):59-66. PubMed ID: 32015295 [TBL] [Abstract][Full Text] [Related]
8. The Role of Radiolabeled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for the Evaluation of Renal Cancer. Evangelista L; Basso U; Maruzzo M; Novara G Eur Urol Focus; 2020 Jan; 6(1):146-150. PubMed ID: 30120074 [TBL] [Abstract][Full Text] [Related]
10. von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806 [TBL] [Abstract][Full Text] [Related]
11. Prostate-Specific Membrane Antigen Use in Glioma Management: Past, Present, and Future. McBriar JD; Shafiian N; Scharf S; Boockvar JA; Wernicke AG Clin Nucl Med; 2024 Sep; 49(9):806-816. PubMed ID: 38968568 [TBL] [Abstract][Full Text] [Related]
12. Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with Matsuda M; Ishikawa E; Yamamoto T; Hatano K; Joraku A; Iizumi Y; Masuda Y; Nishiyama H; Matsumura A J Neurooncol; 2018 Jul; 138(3):581-589. PubMed ID: 29524126 [TBL] [Abstract][Full Text] [Related]
13. PET/CT in comparison with PET/MRI as an imaging modality in the management of Gliomas: A systematic review and meta analysis. Al-Lami BS; Al-Lami BS; Al-Lami YS J Med Imaging Radiat Sci; 2024 Jun; 55(2):330-338. PubMed ID: 38490940 [TBL] [Abstract][Full Text] [Related]
14. PET/MRI in prostate cancer: a systematic review and meta-analysis. Evangelista L; Zattoni F; Cassarino G; Artioli P; Cecchin D; Dal Moro F; Zucchetta P Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):859-873. PubMed ID: 32901351 [TBL] [Abstract][Full Text] [Related]
15. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers. Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427 [TBL] [Abstract][Full Text] [Related]
16. PSMA PET/MR is a New Imaging Option for Identifying Glioma Recurrence and Predicting Prognosis. Xiong M; Chen Z; Zhou C; Yang X; Hu W; Jiang Y; Zheng R; Fan W; Mou Y; Lin X Recent Pat Anticancer Drug Discov; 2024; 19(3):383-395. PubMed ID: 38214322 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous Eiber M; Weirich G; Holzapfel K; Souvatzoglou M; Haller B; Rauscher I; Beer AJ; Wester HJ; Gschwend J; Schwaiger M; Maurer T Eur Urol; 2016 Nov; 70(5):829-836. PubMed ID: 26795686 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic and grading accuracy of Xiao J; Jin Y; Nie J; Chen F; Ma X BMC Cancer; 2019 Aug; 19(1):767. PubMed ID: 31382920 [TBL] [Abstract][Full Text] [Related]